Form 4 Tracker
David O. Watson

General Counsel · 4 filings · Latest: May 14, 2026

Apellis Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
APLS
David O. WatsonGeneral CounselJan 22, 2026
Sale
$21.777,832$170.5K88,531
APLS
Watson David O.—Jan 22, 2026
Proposed Sale
$21.777,832$170.5K—
APLS
David O. WatsonGeneral CounselJan 20, 2026
Sale
$19.792,475$49.0K96,363
APLS
Watson David O.—Jan 20, 2026
Proposed Sale
$19.792,475$49.0K—
APLS
Watson David O.—Jan 13, 2026
Proposed Sale
$22.195,780$128.2K—
APLS
Watson David O.—Dec 16, 2025
Proposed Sale
$24.495,000$122.5K—
APLS
Watson David O.—Nov 17, 2025
Proposed Sale
$20.065,000$100.3K—
APLS
Watson David O.—Oct 16, 2025
Proposed Sale
$25.225,000$126.1K—
APLS
Watson David O.—Sep 16, 2025
Proposed Sale
$24.345,000$121.7K—
APLS
THE DAVID O WATSON IRREV TR OF 2023—Sep 10, 2025
Proposed Sale
$26.1720,000$523.4K—
APLS
Watson David O.—Aug 18, 2025
Proposed Sale
$27.805,000$139.0K—
APLS
Watson David O.—Jul 16, 2025
Proposed Sale
$19.555,000$97.8K—
APLS
Watson David O.—Jun 16, 2025
Proposed Sale
$18.775,000$93.8K—
APLS
DAVID OSBORNE WATSON—Mar 5, 2025
Proposed Sale
$25.105,569$139.8K—
APLS
Watson David O.—Jan 29, 2025
Proposed Sale
$29.52695$20.5K—
APLS
Watson David O.—Jan 22, 2025
Proposed Sale
$30.433,323$101.1K—
APLS
Watson David O.—Jan 17, 2025
Proposed Sale
$29.962,201$65.9K—
APLS
Watson David O.—Jan 13, 2025
Proposed Sale
$28.705,056$145.1K—
APLS
DAVID OSBORNE WATSON—Dec 11, 2024
Proposed Sale
$34.245,000$171.2K—